KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Non-Current Deferred Tax Liability (2020 - 2022)

GoodRx Holdings' Non-Current Deferred Tax Liability history spans 3 years, with the latest figure at $650000.0 for Q3 2022.

  • On a quarterly basis, Non-Current Deferred Tax Liability changed N/A to $650000.0 in Q3 2022 year-over-year; TTM through Sep 2022 was $650000.0, a N/A change, with the full-year FY2021 number at $244000.0, changed N/A from a year prior.
  • Non-Current Deferred Tax Liability hit $650000.0 in Q3 2022 for GoodRx Holdings, up from $455000.0 in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for GDRX hit a ceiling of $1.8 million in Q3 2020 and a floor of $244000.0 in Q4 2021.
  • Historically, Non-Current Deferred Tax Liability has averaged $703600.0 across 3 years, with a median of $455000.0 in 2022.